Comment on Bristol-Myers: FDA blocks hepatitis C drug for now

Bristol-Myers: FDA blocks hepatitis C drug for now

NEW YORK (AP) — U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir. The company says data it submitted to the Food and Drug Administration to win approval of daclatasvir focused on that drug's use with asunaprevir. However, the New York-based drugmaker in October withdrew its application for approval of asunaprevir.Read more on NewsOK.com

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News